1. Setting the scene : the context of drug development 

Marc Czarka

12-01-2021 13:30-16:30

2. Integrated product development : from discovery phase to market authorization

Peter Hendrickx

14-01-2021 13:30-16:30

3. Drug screening : from animals to recombinant proteins and translational research 

3.1 Testing in animals : current use, ethical and regulatory aspects, limits and alternative approachs

Remi Rosière

15-01-2021 13:30-16:30

3.2 High Troughput Screening : setting-up of new functional assays, robustness, troughput and quality of assays

Vincent Dupriez

28-01-2021 14:00-17:00

3.3 Systems biology and translational research

Benjamin Dizier

29-01-2021 14:00-17:00

4. Big Data and personnalized medecine : How AI can potentially reinvent the drug design and development ?

Bruno Josso

23-02-2021 14:00-17:00

02-03-2021 14:00-17:00

04-03-2021 14:00-17:00

WORKSHOP (Assignement 1) : Big data, AI and healthcare environment

Bruno Josso et David Gruson

12-03-2021 14:00-17:00

1. Pre-clinical strategy and Study design 

Jean-Pierre VALENTIN   23/03/2021  14:00-17:00

2. Pre-clinical safety  : Principles of pharmacology and toxicology 

2.2.1 Non-clinical testing for chemical and biological compounds, including Pharmacology (ADME)

Denis GOSSEN   26-03-2021  14:00-17:00

2.2.2 How to choose the dose for first in human administration ?

Denis GOSSEN    30-03-2021  14:00-17:00

2.2.3 Toxicology testing (Part I)

Annick CAUVIN & Helga GERETS   01-04-2021  14:00-17:00

2.2.4 Toxicology testing (Part II)

Annie DELAUNOIS & Annick CAUVIN  02-04-2021  14:00-17:00

2.2.5 Genetic and genomic factors in drug development and response

Csilla SIPEKI, James STALEY, Ciara VANGJELI & Martin ARMSTRONG    20-04-2021  14:00-17:00

2.2.6 Novel approaches in investigative toxicology

Reiner CLASS   23-04-2021   14:00-17:00

2.2.7 In silico/Computational toxicology

Lennart ANGER   27-04-2021   14:00-17:00

3. Drug formulation 

2.3.1 Main aspects of Drug formulation & Concept of drug bioavailability

Jonathan GOOLE   30-04-2021   14:00-17:00

2.3.2 Non-conventional dosage forms & Nanotechnologies for Drug delivery

Jonathan GOOLE   04-05-2021   14:00-17:00

4. Manufacturing  

2.4.1 Pharmaceutical technical development & Quality Management System

Christophe ALLARD   27-05-2021   14:00-17:00

2.4.2 GMPs and required structures in manufacturing & Inspection-operating environment

Christophe ALLARD   28-05-2021   14:00-17:00

5. Moving to First-in-Human studies

2.5.1 Ethics in the Pharmaceutical Industry

Ingrid KLINGMANN   10-06-2021   14:00-17:00

2.5.2 Requirements, ethics and regulations of First-in-Human studies

Ingrid KLINGMANN   11-06-2021   14:00-17:00

2.5.3 Accelerating the move to clinical trials (computer assisted modelling on the way of proof of concept)

Hatice ALDEMIR   15-06-2021   14:00-17:00

2.5.4 Strategic importance, design and practical organisation of Phase I studies

Nariné BARIRIAN  18-06-2021   14:00-17:00

September 2021 – December 2021

January 2022 – March 2022

May 2022 – June 2022

September 2022 – November 2022